Heart BMJ

MARCH 26, 2025

Background Heart failure with preserved ejection fraction is a recognised outcome in patients with myocardial infarction, although heart failure with reduced ejection fraction is more common.

Aortic valve 52

Aortic valve Myocardial Infarction Preserved Ejection Fraction Heart Failure 52

Stroke Journal

OCTOBER 18, 2023

We conducted a post hoc analysis of RICAMIS to investigate whether large artery atherosclerosis (LAA) subtype contributed to the outcomes.METHODS:This is a post hoc analysis of the RICAMIS trial. The primary outcome was excellent functional outcome at 90 days, defined as modified Rankin Scale score of 0 to 1. were women.

Atherosclerosis 40

Atherosclerosis Stroke Strokes Outcomes 40

Circulation

NOVEMBER 11, 2024

Introduction:It remains uncertain whether dietary supplementation of marine n-3 polyunsaturated fatty acids (PUFAs) improves atherosclerosis and lipoprotein subclasses in patients with type 2 diabetes (T2D). The primary outcome was the prevalence of carotid artery plaques assessed by ultrasound. day) or low-dose (1.5g/day)

Atherosclerosis 40

Atherosclerosis Diabetes Plaque Cholesterol 40

Medical Xpress - Cardiology

FEBRUARY 14, 2025

Comprehensive assessments are needed in this vulnerable group to improve survival outcomes and quality of care for cancer patients.

Cancer 52

Cancer Atherosclerosis Risk Factors Heart Disease 52

Stroke Journal

JANUARY 30, 2025

Background:Intracranial atherosclerosis (ICAS) is a common stroke cause, with a recurrent stroke risk of up to 18% per year despite treatment advances. The primary outcome was the incidence of stroke. Conclusions:Lipid-lowering therapies significantly reduce the risk of ischemic stroke in patients with intracranial atherosclerosis.

Atherosclerosis 40

Atherosclerosis Stroke Strokes Hypertension 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCerebrovascular disease (CVD), particularly carotid artery atherosclerosis, contributes substantially to global morbidity and mortality. The ability to precisely detect atherosclerosis is crucial, as it directly influences patient management, including decisions regarding surgical interventions.

Atherosclerosis 40

Atherosclerosis Atrial Fibrillation Stents Stent 40

Cardiology Update

JANUARY 2, 2024

European Atherosclerosis Society (EAS) Congress 2024 Date: May 26-29, 2024 Location: Lyon, France and online Overview: The European Atherosclerosis Society (EAS) and the New French Society of Atherosclerosis will be hosting the 92 nd EAS Congress, to be held in the city of Lyon. Hashtag: #ICNCCT2024 7.

Heart Failure 111

Heart Failure Atherosclerosis Cardiovascular Imaging Non-Invasive Cardiology 111

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundChronic inflammatory disease (CID) accelerates atherosclerosis and the development of aortic stenosis. Data on long‐term outcomes after transcatheter aortic valve implantation (TAVI) in those patients are missing. Long‐term (up to 5 years) clinical and echocardiographic outcomes were studied.

Aortic valve 49

Aortic valve Aortic Outcomes Atrial Fibrillation 49

Stroke Journal

JANUARY 30, 2025

Stroke subtype was examined using TOAST classification: 1) large artery atherosclerosis; 2) cardioembolic; 3) small vessel occlusion; 4) other known etiology (e.g., Compared to the pre-COVID period, the COVID period had a lower proportion of strokes from large artery atherosclerosis (17.6% vs. 21.2%, p=0.02) during the COVID period.

COVID-19 40

COVID-19 Stroke Strokes Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Background:Intracranial Atherosclerosis (ICAS) leads to stroke by perforator disease, artery to artery embolism, and impaired distal flow/perfusion. The study outcome is recurrent ischemic stroke. Stroke, Volume 55, Issue Suppl_1 , Page ATMP72-ATMP72, February 1, 2024. Patients generally underwent perfusion imaging with MRI.

Atherosclerosis 40

Atherosclerosis Embolism Plaque Strokes 40

Stroke Journal

FEBRUARY 1, 2024

We explored differences in clinical outcomes and successful recanalization rates between EVT and MM.Methods:From SELECT2 randomized clinical trial, patients were categorized based on Stroke etiology: Large-artery atherosclerosis (LAA), Cardioembolism (CE), Stroke of other determined etiology (SOE), and Stroke of undetermined etiology (SUE).

Stroke 40

Stroke Strokes Outcomes Atherosclerosis 40

The American Journal of Cardiology

JUNE 23, 2024

Publication date: Available online 23 June 2024 Source: The American Journal of Cardiology Author(s): Ebenezer Oni, Ellen Boakye, Gregg S. Pressman, Zeina Dardari, Kunal Jha, Moyses Szklo, Matthew Budoff, Khurram Nasir, Timothy M. Hughes, Michael J.

Atherosclerosis 40

Atherosclerosis Bicuspid/Mitral Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionIntracranial atherosclerosis‐related large vessel occlusion (ICAS‐LVO) is a common cause of failed mechanical thrombectomy (MT) in acute ischemic stroke (AIS) [1]. Treatment of ICAS‐LVO with rescue stenting and/or angioplasty has shown promising outcomes, but diagnosing ICAS‐LVO during MT can be challenging [2, 3].

Atherosclerosis 40

Atherosclerosis Angioplasty Stent Stents 40

Stroke Journal

FEBRUARY 1, 2024

The most common category under the TOAST criteria was large artery atherosclerosis (39.2%). of patients.Conclusion:Our data suggests that CRIS may have a higher association with large artery atherosclerosis. Among the cocaine-positive cohort, 10.8% of patients received thrombolytics and 18.9% underwent endovascular thrombectomy.

Stroke 40

Stroke Strokes Atherosclerosis Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

1) Nevertheless, published research on endovascular treatment outcomes in this population is scarce. 2, 3) In this study, we compared the clinical outcomes of TL patients with the two etiologies.MethodsA retrospective analysis was performed on a multicenter cohort of patients with TLs who underwent endovascular treatment.

Outcomes 40

Outcomes Atherosclerosis Hemorrhage Diabetes 40

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 15, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Angina 40

Angina Atherosclerosis Circulation Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Background:The association between left ventricular injury (LVI) detected by cardiac magnetic resonance imaging (CMR) and the risk of a subsequent ischemic stroke is unknown.Methods:We studied stroke-free participants in the Multi-Ethnic Study of Atherosclerosis study who underwent a steady-state free precession CMR at Exam 5 (2010-2012).

Atherosclerosis 40

Atherosclerosis Stroke Strokes Atrial Fibrillation 40

DAIC

FEBRUARY 3, 2025

2 Molarity assay aligns with Roches commitment to lead with science in order to develop transformational solutions that help improve patient outcomes and simplify lab operations. The development of the Tina-quant Lipoprotein (a) Gen.2 2022 Aug, 80 (9) 934946 Kronenberg F.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

Stroke Journal

APRIL 3, 2024

Steno-occlusive changes in the posterior cerebral arteries (PCAs) may contribute to worsened outcomes in patients with MMD; however, there is little information on the incidence and natural history of posterior circulation MMD (PCMMD). Demographics, perioperative outcomes, and radiological phenotypes were recorded for 770 patients.

Circulation 40

Circulation Outcomes Academic Atherosclerosis 40

Stroke Journal

JANUARY 30, 2025

Accurate prediction of stroke recurrence is critical for improving patient outcomes through timely and targeted interventions. The study outcome was recurrent ischemic stroke by day 30. Background:Symptomatic intracranial atherosclerotic disease carries a high stroke recurrence rate. Variables with p<0.05

Stroke 40

Stroke Strokes Atherosclerosis Stenosis 40

Journal of Clinical Investigation - Cardiology

JANUARY 16, 2024

Gestational diabetes is a common medical complication of pregnancy that is associated with adverse perinatal outcomes and an increased risk of metabolic diseases and atherosclerosis in adult offspring. The mechanisms responsible for this delayed pathological transmission remain unknown.

Diabetes 52

Diabetes Atherosclerosis Outcomes 52

Stroke Journal

FEBRUARY 1, 2024

Patients with acute basilar artery occlusion were classified into three groups according to stroke etiology: large-artery atherosclerosis (LAA), cardioembolism (CE), and undetermined/other determined cause (UC/ODC). The primary outcome was favorable outcome (modified Rankin scale 0-3) at 90 days. 6.71), CE group (52.2%

Outcomes 40

Outcomes Hemorrhage Atherosclerosis Strokes 40

Circulation

JANUARY 24, 2024

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Stroke Strokes 81

Stroke Journal

JANUARY 30, 2025

In this study, we examined the rates of ischemic stroke in the territory of the qualifying artery (SIT) periprocedurally as well as over time between MMT alone and stent+MMT.Methods:The primary outcome of interest was SIT. Periprocedural stroke was defined as <7d from stent placement.

Stroke 40

Stroke Strokes Stent Stents 40

Stroke Journal

FEBRUARY 1, 2024

We assessed the clinical outcomes of endovascular treatment in acute large vessel occlusion (LVO) strokes caused by ICAD and compared them with large vessel occlusion strokes not associated with intracranial atherosclerosis (non-ICAD LVO).Methods:Our vs. 4%, p = 0.008). 1.13, p=0.118).Conclusion:Our 1.13, p=0.118).Conclusion:Our

Stroke 40

Stroke Strokes Outcomes Angioplasty 40

Frontiers in Cardiovascular Medicine

MARCH 4, 2024

The complex development of atherosclerosis manifests as intimal plaque which occurs in the presence or absence of traditional risk factors. Atherosclerotic coronary artery disease (CAD) is the causal pathological process driving most major adverse cardiovascular events (MACE) worldwide.

Plaque 59

Plaque Coronary Artery Disease Blood Pressure Cardiovascular Disease 59

Stroke Journal

FEBRUARY 1, 2024

31 patients (18%) had stroke etiology as Large Artery Atherosclerosis (per TOAST criteria). In contrast, patients for whom TOAST criteria was not “Large Artery Atherosclerosis”, had a median initial NIHSS 9 and median discharge NIHSS 2. Further studies are needed to determine why young adults with LVO with LAA have worse outcomes.

Stroke 40

Stroke Strokes Atherosclerosis Thrombolysis 40

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundAortic stenosis has pathophysiological similarities with atherosclerosis, including the deposition of cholesterol‐containing lipoproteins. Journal of the American Heart Association, Ahead of Print. In multivariate analysis, low CCDR (hazard ratio, 2.21 [95% CI, 0.99–4.92],P=0.04)

Aortic valve 40

Aortic valve Cholesterol Aortic Stenosis 40

Cardiometabolic Health Congress

OCTOBER 25, 2024

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Ballantyne, MD , explored Lipoprotein(a).

CME 64

CME Innovation Education Atherosclerosis 64

The British Journal of Cardiology

FEBRUARY 20, 2024

One of the assessments for coronary atherosclerosis during cardiac computed tomography (CT) is coronary artery calcium (CAC) scoring. We conducted analysis on the determinants of high-risk coronary calcification, represented by CAC score, among women as a step to improve their outcomes and prognosis.

Blood Pressure 52

Blood Pressure Chest Pain Atherosclerosis Diabetes 52

Physiologically Speaking

JANUARY 5, 2024

And the more you exercise, the better your outcomes. On the other hand, people who already have CVD or have suffered a CVD event can significantly improve their long-term outcomes by adopting a structured exercise program. One the one hand, participating in aerobic and resistance exercise reduce the incidence of CVD.

Plaque 119

Plaque Physiology Exercise Cholesterol 119

Journal of the American Heart Association

FEBRUARY 26, 2025

BackgroundPlaque progression (PP) is critical between subclinical atherosclerosis and plaque rupture. Intensive control of sdLDLC along with other risk factors should be considered to mitigate PP and improve cardiovascular outcomes. Journal of the American Heart Association, Ahead of Print.

Ultrasound 56

Ultrasound Plaque Cholesterol Coronary Artery Disease 56

Cardiometabolic Health Congress

JULY 25, 2024

The conference will equip health professionals with clinical strategies that promote comprehensive health and tools to harness new therapies to improve our collective health outcomes. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.

Education 100

Education Innovation Risk Factors Obesity 100

Journal of the American Heart Association

FEBRUARY 29, 2024

BackgroundResolvin D2 (RvD2) has been reported to protect against the development of atherosclerosis in animal models. Adjusted hazard ratios and 95% CIs for ASCVD outcomes according to baseline RvD2 levels were calculated using Cox proportional hazards models. Journal of the American Heart Association, Ahead of Print.

Cholesterol 63

Cholesterol Cardiovascular Disease Atherosclerosis Outcomes 63

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

The complications of the procedure and patient’s outcomes were discussed.MethodsWe identified two patients who were admitted to our medical center between January 2022 to December 2022 for subclavian‐carotid artery bypass procedure. Clinical data were reviewed retrospectively.ResultsCase 1.

Outcomes 40

Outcomes Chest Pain Coronary Artery Disease Aortic 40

Frontiers in Cardiovascular Medicine

JUNE 30, 2024

Identifying new targeted therapeutic approaches has become a priority of biomedical research to improve patient outcomes and quality of life. Cardiovascular disease (CVD) represents the leading cause of mortality and disability all over the world.

Cardiovascular Disease 52

Cardiovascular Disease Quality of Life Myocardial Infarction Aneurysm 52

Stroke Journal

FEBRUARY 1, 2024

Background:Ischemic stroke can arise from various etiologies, such as cardioembolism, atherosclerosis, small vessel disease or cryptogenic. Accumulating evidence suggests that an imbalance of neuroprotective and neuroinflammatory cytokines may contribute to stroke outcomes. pg/ml) as compared to cardioembolic (35.6±6.5 p<0.01).Conclusions:Our

Biomarkers 40

Biomarkers Stroke Strokes Atherosclerosis 40